Survival Technologies files DRHP with SEBI for Rs 1,000 crore IPO
The company is one of the most profitable companies manufacturing speciality chemicals in India
The company is one of the most profitable companies manufacturing speciality chemicals in India
The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics
The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come
Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
The current ruling will assure the safety of the use of Ranitidine for Indian patients
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
Subscribe To Our Newsletter & Stay Updated